{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:23:37Z","timestamp":1775744617594,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T00:00:00Z","timestamp":1757808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI22\/00211"],"award-info":[{"award-number":["PI22\/00211"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7278"],"award-info":[{"award-number":["P2022\/BMD-7278"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nefroe.2025.501347","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:50:59Z","timestamp":1758786659000},"page":"501347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relevance of the interactions between the complement and contact coagulation systems on renal pathology"],"prefix":"10.1016","volume":"45","author":[{"given":"Alberto","family":"L\u00f3pez-Lera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6418-5647","authenticated-orcid":false,"given":"Fernando","family":"Corvillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-2423","authenticated-orcid":false,"given":"Laura","family":"Gonz\u00e1lez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-414X","authenticated-orcid":false,"given":"Marta","family":"Melgosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4212-1233","authenticated-orcid":false,"given":"Pilar","family":"S\u00e1nchez-Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2025.501347_bib0005","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0010","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.501347_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2010.08295.x","article-title":"Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome","volume":"150","author":"S\u00e1nchez-Corral","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0020","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.kint.2024.05.015","article-title":"The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"106","author":"Vivarelli","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2025.501347_bib0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system part I \u2014 molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0035","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.imbio.2012.07.021","article-title":"Complement dysregulation and disease: from genes and proteins to diagnostics and drugs","volume":"217","author":"de Cordoba","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.nefroe.2025.501347_bib0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41581-021-00424-4","article-title":"Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics","volume":"17","author":"Fakhouri","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0045","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2010030315","article-title":"Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome","volume":"21","author":"Dragon-Durey","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.molimm.2015.03.246","article-title":"Atypical aHUS: state of the art","volume":"67","author":"Nester","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1011580","article-title":"CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: prevalence, genomic characterization and impact on outcome","volume":"13","author":"Piras","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0060","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931210","article-title":"Anti-factor H antibody and its role in atypical hemolytic uremic syndrome","volume":"13","author":"Raina","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0070","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome","volume":"45","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.nefroe.2025.501347_bib0075","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2215\/CJN.01640214","article-title":"Complement mutations in diacylglycerol kinase-\u03b5-associated atypical hemolytic uremic syndrome","volume":"9","author":"S\u00e1nchez Chinchilla","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nefroe.2025.501347_bib0085","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.kint.2023.07.020","article-title":"On the relevance of thrombomodulin variants in atypical hemolytic uremic syndrome","volume":"104","author":"Huerta","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2025.501347_bib0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1681\/ASN.2013050453","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","volume":"25","author":"Bu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108794","article-title":"von Willebrand factor variants in C3 glomerulopathy: a Chinese cohort study","volume":"229","author":"Chen","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0100","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1182\/blood.V90.10.3819","article-title":"Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes","volume":"90","author":"Colman","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.nefroe.2025.501347_bib0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-800100-4.00002-7","article-title":"Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway","volume":"121","author":"Kaplan","year":"2014","journal-title":"Adv Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nefroe.2025.501347_bib0115","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/jth.13235","article-title":"Contact system revisited: an interface between inflammation, coagulation, and innate immunity","volume":"14","author":"Long","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nefroe.2025.501347_bib0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3389\/fmed.2020.00358","article-title":"Measurement of Bradykinin formation and degradation in blood plasma: relevance for acquired angioedema associated with angiotensin converting enzyme inhibition and for hereditary angioedema due to factor XII or plasminogen gene variants","volume":"7","author":"Marceau","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.nefroe.2025.501347_bib0125","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/all.15013","article-title":"Identification of novel biomarkers to distinguish bradykinin-mediated angioedema from mast cell-\/histamine-mediated angioedema","volume":"77","author":"Bindke","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.nefroe.2025.501347_bib0130","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/0006-2952(86)90726-4","article-title":"Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme","volume":"35","author":"Sheikh","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2010.08.008","article-title":"Effect of interferon-\u03b3 on inflammatory cytokine-induced bradykinin B1 receptor expression in human vascular cells","volume":"647","author":"Koumbadinga","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-013-1126-9","article-title":"Kinin-stimulated B1 receptor signaling depends on receptor endocytosis whereas B2 receptor signaling does not","volume":"39","author":"Enquist","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1016\/j.nefroe.2025.501347_bib0145","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1016\/S0021-9258(18)89258-4","article-title":"Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes","volume":"260","author":"Harpel","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nefroe.2025.501347_bib0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.129.2.315","article-title":"The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C\u20191r subcomponent of the first component of complement by serum C\u20191 esterase inhibitor","volume":"129","author":"Ratnoff","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.nefroe.2025.501347_bib0155","first-page":"53","article-title":"Studies on contact activation: effects of surface and inhibitors","volume":"15","author":"Cameron","year":"1989","journal-title":"Med Prog Technol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0160","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4049\/jimmunol.105.4.802","article-title":"A pre-albumin activator of prekallikrein","volume":"105","author":"Kaplan","year":"1970","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0165","doi-asserted-by":"crossref","first-page":"17962","DOI":"10.1074\/jbc.M106101200","article-title":"Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator","volume":"277","author":"Shariat-Madar","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nefroe.2025.501347_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020036","article-title":"Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1","volume":"6","author":"Dob\u00f3","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2025.501347_bib0175","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1073\/pnas.022626899","article-title":"Heat shock protein 90 catalyzes activation of the prekallikrein-kininogen complex in the absence of factor XII","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nefroe.2025.501347_bib0180","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1515\/bc.2010.102","article-title":"Activation of the plasma kallikrein-kinin system on human lung epithelial cells","volume":"391","author":"della Vergiliana","year":"2010","journal-title":"Biol Chem"},{"key":"10.1016\/j.nefroe.2025.501347_bib0185","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaz0274","article-title":"The human secretome","volume":"12","author":"Uhl\u00e9n","year":"2019","journal-title":"Sci Signal"},{"key":"10.1016\/j.nefroe.2025.501347_bib0190","first-page":"F486","article-title":"Bradykinin increases cytosolic free [Ca2+] in proximal tubule cells","volume":"255","author":"Aboolian","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0195","first-page":"F808","article-title":"Bradykinin activates protein kinase C in cultured cortical collecting tubular cells","volume":"257","author":"Dixon","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0200","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1097\/01.ASN.0000136132.20189.95","article-title":"Bradykinin decreases plasminogen activator inhibitor-1 expression and facilitates matrix degradation in the renal tubulointerstitium under angiotensin-converting enzyme blockade","volume":"15","author":"Okada","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0205","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1681\/ASN.V10102120","article-title":"Polymorphisms in the genes encoding for human kinin receptors and the risk of end-stage renal failure: results of transmission\/disequilibrium test. The End-Stage Renal Disease Study Group","volume":"10","author":"Zychma","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF03260059","article-title":"Association of the human bradykinin B2 receptor gene with chronic renal failure","volume":"8","author":"Jozwiak","year":"2004","journal-title":"Mol Diagn"},{"key":"10.1016\/j.nefroe.2025.501347_bib0215","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/ki.2011.14","article-title":"Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis","volume":"79","author":"Pereira","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.nefroe.2025.501347_bib0220","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2337\/diabetes.52.5.1215","article-title":"Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes","volume":"52","author":"Jaffa","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.nefroe.2025.501347_bib0225","doi-asserted-by":"crossref","first-page":"F483","DOI":"10.1152\/ajprenal.00165.2004","article-title":"Mechanisms through which bradykinin promotes glomerular injury in diabetes","volume":"288","author":"Tan","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0230","doi-asserted-by":"crossref","first-page":"F1026","DOI":"10.1152\/ajprenal.00203.2007","article-title":"Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy","volume":"293","author":"Tan","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2024.109229","article-title":"The contact system in chronic kidney disease and hemodialysis \u2014 a cross-sectional study","volume":"245","author":"Palarasah","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.nefroe.2025.501347_bib0240","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1357-2725(02)00262-5","article-title":"The renin-angiotensin and the kallikrein-kinin systems","volume":"35","author":"Campbell","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0245","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1470320312474854","article-title":"Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems","volume":"15","author":"Su","year":"2014","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.nefroe.2025.501347_bib0250","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/imr.12469","article-title":"The complement and contact activation systems: partnership in pathogenesis beyond angioedema","volume":"274","author":"Ghebrehiwet","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nefroe.2025.501347_bib0255","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.nefroe.2025.501347_bib0260","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0265","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000484257","article-title":"Kallikrein cleaves C3 and activates complement","volume":"10","author":"Irmscher","year":"2018","journal-title":"J Innate Immun"},{"key":"10.1016\/j.nefroe.2025.501347_bib0270","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/jth.14209","article-title":"Hereditary angioedema: the plasma contact system out of control","volume":"16","author":"De Maat","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nefroe.2025.501347_bib0275","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3389\/fimmu.2019.00991","article-title":"MASP-1 increases endothelial permeability","volume":"10","author":"Debreczeni","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035690","article-title":"Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation","volume":"7","author":"Hess","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nefroe.2025.501347_bib0285","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molimm.2015.02.014","article-title":"MASP-1 of the complement system promotes clotting via prothrombin activation","volume":"65","author":"Jenny","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-5793(81)80906-4","article-title":"Proteolysis of factor B by plasma kallikrein and plasmin","volume":"131","author":"Ikari","year":"1981","journal-title":"FEBS Lett"},{"key":"10.1016\/j.nefroe.2025.501347_bib0295","first-page":"587","article-title":"The activation of the alternative pathway C3 convertase by human plasma kallikrein","volume":"45","author":"DiScipio","year":"1982","journal-title":"Immunology"},{"key":"10.1016\/j.nefroe.2025.501347_bib0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/imr.13129","article-title":"Structural studies offer a framework for understanding the role of properdin in the alternative pathway and beyond","volume":"313","author":"Pedersen","year":"2023","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nefroe.2025.501347_bib0305","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12715","article-title":"Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation","volume":"6","author":"Heal","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.nefroe.2025.501347_bib0310","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/jth.14742","article-title":"Contact activation-induced complex formation between complement factor H and coagulation factor XIIa","volume":"18","author":"Thangaraj","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.nefroe.2025.501347_bib0315","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2008.04.027","article-title":"Plasma kallikrein is activated on dermatan sulfate and cleaves factor H","volume":"370","author":"Saito","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nefroe.2025.501347_bib0320","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4049\/jimmunol.2000398","article-title":"Cross-talk between the complement pathway and the contact activation system of coagulation: activated factor XI neutralizes complement factor H","volume":"206","author":"Puy","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0325","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12967-024-05216-5","article-title":"Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system","volume":"22","author":"Wisniewski","year":"2024","journal-title":"J Transl Med"},{"key":"10.1016\/j.nefroe.2025.501347_bib0330","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41423-022-00854-5","article-title":"A role for complement blockade in kidney transplantation","volume":"19","author":"Karpman","year":"2022","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0335","author":"Shire"},{"key":"10.1016\/j.nefroe.2025.501347_bib0340","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2215\/CJN.04840419","article-title":"Three-year outcomes of a randomized, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients","volume":"15","author":"Huang","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.nefroe.2025.501347_bib0345","series-title":"DM199 for pregnancy complications","year":"2025"},{"key":"10.1016\/j.nefroe.2025.501347_bib0350","series-title":"Multiple doses of DM199 in patients with chronic kidney disease (REDUX)","year":"2022"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142500118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S201325142500118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:13:00Z","timestamp":1773159180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S201325142500118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S201325142500118X"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501347","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relevance of the interactions between the complement and contact coagulation systems on renal pathology","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2025.501347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2025.501347","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Nefrolog\u00eda.","name":"copyright","label":"Copyright"}],"article-number":"501347"}}